People taking the maximum dose (15 mg) lost an average of 22.5% of their body weight over 72 weeks, compared to 14.9% with Wegovys maximum dose (2.4 mg) over 68 weeks
Emerging research suggests these medications may offer unexpected mental health benefits, with observational studies indicating potential reductions in depression symptoms among users
By targeting appetite, metabolism, and growth hormone pathways simultaneously, these treatments provide a powerful, science-based approach to achieving lasting results
They also create an opportunity to adjust the dose, address nutrition barriers, and evaluate whether the medication continues to offer more benefit than burden
If you liked this post, you might also enjoy: Xox, SKH Janie Greene is